RCAR Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.03 - $0.35
Previous CloseN/A
Volume275.00
Average Volume (3M)0.00
Market Cap
$87.00
Enterprise Value-$2.81M
Total Cash (Recent Filing)$100.74K
Total Debt (Recent Filing)$800.00K
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding87,352,360
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)10.40
Price to Sales (P/S)0.00
P/FCF Ratio-5.35
Enterprise Value/Market Cap-32.30K
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.01K
Enterprise Value/Ebitda0.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RCAR FAQ
What was RenovaCare Inc’s price range in the past 12 months?
RenovaCare Inc lowest stock price was $0.03 and its highest was $0.35 in the past 12 months.
What is RenovaCare Inc’s market cap?
RenovaCare Inc’s market cap is $87.00.
When is RenovaCare Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were RenovaCare Inc’s earnings last quarter?
RenovaCare Inc released its earnings results on Nov 19, 2018. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is RenovaCare Inc overvalued?
According to Wall Street analysts RenovaCare Inc’s price is currently Overvalued.
Does RenovaCare Inc pay dividends?
RenovaCare Inc does not currently pay dividends.
What is RenovaCare Inc’s EPS estimate?
RenovaCare Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RenovaCare Inc have?
RenovaCare Inc has 87,352,360 shares outstanding.
What happened to RenovaCare Inc’s price movement after its last earnings report?
RenovaCare Inc reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of RenovaCare Inc?
Currently, no hedge funds are holding shares in RCAR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
RenovaCare Inc
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
Technical Analysis
Aethlon Medical
―
Xenetic Biosciences
―
Enveric Biosciences
―
Bluejay Diagnostics
―
Virax Biolabs Group Ltd. Class A
―